Continuing drug shortage issues are a result of economic and policy failures that span many years, FDA Commissioner Scott Gottlieb told a crowd of researchers, health care providers, industry representatives and other experts during the agency’s Tuesday (Nov. 27) drug shortages public meeting, held in coordination with the Duke Margolis Center for Health Policy. In a discussion guide released in advance of the Tuesday meeting , Duke echoes some of the same root causes cited by Gottlieb, and adds that...